98 related articles for article (PubMed ID: 19569048)
1. The influence of cosmetic breast augmentation on the stage distribution and prognosis of women subsequently diagnosed with breast cancer.
Xie L; Brisson J; Holowaty EJ; Villeneuve PJ; Mao Y
Int J Cancer; 2010 May; 126(9):2182-90. PubMed ID: 19569048
[TBL] [Abstract][Full Text] [Related]
2. Do breast implants adversely affect prognosis among those subsequently diagnosed with breast cancer? Findings from an extended follow-up of a Canadian cohort.
Lavigne E; Holowaty EJ; Pan SY; Xie L; Villeneuve PJ; Morrison H; Brisson J
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1868-76. PubMed ID: 22850806
[TBL] [Abstract][Full Text] [Related]
3. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation.
Brisson J; Holowaty EJ; Villeneuve PJ; Xie L; Ugnat AM; Latulippe L; Mao Y
Int J Cancer; 2006 Jun; 118(11):2854-62. PubMed ID: 16381020
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk among Danish women with cosmetic breast implants.
Friis S; Hölmich LR; McLaughlin JK; Kjøller K; Fryzek JP; Henriksen TF; Olsen JH
Int J Cancer; 2006 Feb; 118(4):998-1003. PubMed ID: 16152592
[TBL] [Abstract][Full Text] [Related]
5. Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival.
Le GM; O'Malley CD; Glaser SL; Lynch CF; Stanford JL; Keegan TH; West DW
Breast Cancer Res; 2005; 7(2):R184-93. PubMed ID: 15743498
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer diagnosis and survival in women with and without breast implants.
Birdsell DC; Jenkins H; Berkel H
Plast Reconstr Surg; 1993 Oct; 92(5):795-800. PubMed ID: 8415960
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer detection and survival among women with cosmetic breast implants: systematic review and meta-analysis of observational studies.
Lavigne E; Holowaty EJ; Pan SY; Villeneuve PJ; Johnson KC; Fergusson DA; Morrison H; Brisson J
BMJ; 2013 Apr; 346():f2399. PubMed ID: 23637132
[TBL] [Abstract][Full Text] [Related]
8. Mortality among Canadian women with cosmetic breast implants.
Villeneuve PJ; Holowaty EJ; Brisson J; Xie L; Ugnat AM; Latulippe L; Mao Y
Am J Epidemiol; 2006 Aug; 164(4):334-41. PubMed ID: 16777929
[TBL] [Abstract][Full Text] [Related]
9. Canadian breast implant cohort: extended follow-up of cancer incidence.
Pan SY; Lavigne E; Holowaty EJ; Villeneuve PJ; Xie L; Morrison H; Brisson J
Int J Cancer; 2012 Oct; 131(7):E1148-57. PubMed ID: 22514048
[TBL] [Abstract][Full Text] [Related]
10. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis in relation to survival following breast cancer: a cohort study.
Brandt J; Garne JP; Tengrup I; Manjer J
World J Surg Oncol; 2015 Feb; 13():33. PubMed ID: 25889186
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer stage at diagnosis and survival among patients with prior breast implants.
Deapen D; Hamilton A; Bernstein L; Brody GS
Plast Reconstr Surg; 2000 Feb; 105(2):535-40. PubMed ID: 10697158
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer following augmentation mammoplasty (United States).
Brinton LA; Lubin JH; Burich MC; Colton T; Brown SL; Hoover RN
Cancer Causes Control; 2000 Oct; 11(9):819-27. PubMed ID: 11075871
[TBL] [Abstract][Full Text] [Related]
14. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles Study.
Deapen DM; Bernstein L; Brody GS
Plast Reconstr Surg; 1997 Apr; 99(5):1346-53. PubMed ID: 9105362
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection.
Schootman M; Fuortes L; Aft R
Breast Cancer Res Treat; 2006 Sep; 99(1):91-5. PubMed ID: 16555124
[TBL] [Abstract][Full Text] [Related]
16. Stage at diagnosis and comorbidity influence breast cancer survival in First Nations women in Ontario, Canada.
Sheppard AJ; Chiarelli AM; Marrett LD; Nishri ED; Trudeau ME
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2160-7. PubMed ID: 21803843
[TBL] [Abstract][Full Text] [Related]
17. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
20. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
